Reverse Phase High Performance Liquid Chromatography method for determination of Lercanidipine hydrochloride in bulk and tablet dosage form

Similar documents
Method Development and Validation Of Prasugrel Tablets By RP- HPLC

Impact factor: 3.958/ICV: 4.10 ISSN:

International Journal of Pharmacy and Pharmaceutical Sciences Vol 2, Issue 1, 2010

Validated RP-HPLC Method for Estimation of Cefprozil in Tablet Dosage Form

International Journal of Pharma and Bio Sciences V1(1)2010. HPLC method for analysis of Lercanidipine Hydrochloride in Tablets

Journal of Pharmaceutical and Biomedical Analysis Letters. Analysis Letters

Journal of Chemical and Pharmaceutical Research

SIMULTANEOUS RP HPLC DETERMINATION OF CAMYLOFIN DIHYDROCHLORIDE AND PARACETAMOL IN PHARMACEUTICAL PREPARATIONS.

International Journal of Current Trends in Pharmaceutical Research. International Journal of Current Trends in Pharmaceutical Research

RP-HPLC Method Development and Validation of Dapagliflozin in Bulk and Tablet formulation

INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND LIFE SCIENCES

Development and Validation of Stability Indicating RP-HPLC Method for the Determination of Anagrelide HCl in Pharmaceutical Formulation

International Journal of Pharmaceutical Research & Analysis

International Journal of Pharma Research and Health Sciences. Available online at

METHOD DEVELOPMENT AND VALIDATION OF RALTEGRAVIR POTASSIUM AND RILPIVIRINE HCL BY HPLC AND HPTLC METHODS

Received: ; Accepted:

Department of Quality Assurance, Luqman College of Pharmacy, GULBARGA (K.S.) INDIA ABSTRACT

A Simple, Novel Validated Stability Indicating RP-HPLC method for estimation of Duloxetine HCl in Capsule Pharmaceutical Formulation

Volume 6, Issue 2, January February 2011; Article-015

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY

Stability indicating RP-HPLC method for determination of azilsartan medoxomil in bulk and its dosage form

Int. J. Pharm. Sci. Rev. Res., 30(2), January February 2015; Article No. 09, Pages: 63-68

STABILITY INDICATING METHOD OF RELATED IMPURITIES IN VENLAFAXINE HYDROCHLORIDE SUSTAINED RELEASE TABLETS

Development of Validated Analytical Method of Mefenamic Acid in an Emulgel (Topical Formulation)

J Pharm Sci Bioscientific Res (4): ISSN NO

7. Stability indicating analytical method development and validation of Ramipril and Amlodipine in capsule dosage form by HPLC.

STABILITY INDICATING RP HPLC METHOD FOR ANALYSIS OF DORZOLAMIDE HCl IN THE BULK DRUG AND IT S PHARMACEUTICAL DOSAGE FORM

Development And Validation Of Rp-Hplc Method For Determination Of Velpatasvir In Bulk

Research Article METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF ELBASVIR AND GRAZOPREVIR BY RP-HPLC

DETERMINATION OF DRUG RELEASE DURING DISSOLUTION OF NICORANDIL IN TABLET DOSAGE FORM BY USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

Received: ; Accepted:

Development and validation a RP-HPLC method: Application for the quantitative determination of quetiapine fumarate from marketed bulk tablets

Development and Validation of Stability-Indicating RP-HPLC Method for Estimation of Atovaquone

Simultaneous estimation of meclizine and nicotinic acid by using RP-HPLC

Available online at Scholars Research Library

Novus International Journal of Analytical Innovations 2012, Vol. 1, No. 3

Stability Indicating RP-HPLC Method for Determination of Valsartan in Pure and Pharmaceutical Formulation

Development and Validation of a HPLC Method for Determination of Anastrozole in Tablet Dosage Form

Method Development and Validation for the Estimation of Darunavir in Rat Plasma by RP-HPLC

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS OF GABAPENTIN IN PURE AND PHARMACEUTICAL FORMULATIONS

Research Article Available online at

DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC METHOD FOR SIMULTANEOUS DETERMINATION OF PREDNISOLONE ACETATE AND OFLOXACIN IN EYE-DROP

Stability-indicating HPLC determination of tolterodine tartrate in pharmaceutical dosage form

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

Journal of Chemical and Pharmaceutical Research, 2012, 4(6): Research Article. Estimation of zaleplon by a new RP-HPLC method

INTERNATIONAL JOURNAL OF UNIVERSAL PHARMACY AND BIO SCIENCES

A RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF PARA- PHENYLENEDIAMINE IN PURE FORM AND IN MARKETED PRODUCTS

Validated spectrophotometric determination of Fenofibrate in formulation

SIMPLE AND SENSITIVE VALIDATED REVERSE PHASE HPLC-UV METHOD FOR THE DETERMINATION OF LYMECYCLINE IN PHARMACEUTICAL DOSAGE FORMS

SIMULTANEOUS ESTIMATION OF CILOSTAZOL AND ASPIRIN IN SYNTHETIC MIXTURE USING HPTLC METHOD

Development and validation of RP-HPLC method for determination of marker in polyherbal marketed Kankasava formulations

Journal of Chemical and Pharmaceutical Research, 2017, 9(1): Research Article

Impact factor: 3.958/ICV: 4.10 ISSN:

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

RP-HPLC Method for Simultaneous Estimation of Atenolol, Hydrochlorothiazide and Losarton in Tablet Dosage form

Pharmacophore 2011, Vol. 2 (4), ISSN Pharmacophore. (An International Research Journal)

IJPRD, 2012; Vol 4(10): December-2012 ( ) International Standard Serial Number

Method Development, Validation and Stability Study of Irbesartan in Bulk and Pharmaceutical Dosage Form by UV-Spectrophotometric Method

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

Asian Journal of Research in Chemistry and Pharmaceutical Sciences Journal home page:

Pelagia Research Library

RP-HPLC Estimation of Trospium Chloride in Tablet Dosage Forms

Scholars Research Library

Research Article. Simultaneous spectrophotometric estimation of Paracetamol and Aceclofenac by second order derivative method in combined dosage form

Spectroscopic Method For Estimation of Atorvastatin Calcium in Tablet Dosage Form

Chapter 4: Verification of compendial methods

Method development and validation of Tinidazole and Ciprofloxacin HCl in bulk and tablet dosage form by Rp-HPLC

DEVELOPMENT AND VALIDATION OF NEW RP-HPLC METHOD FOR THE DETERMINATION OF AFLOQUALONE IN HUMAN PLASMA AND FORMULATION

New Simple UV Spectrophotometric Method for Determination of Mirtazapine in Bulk and pharmaceutical dosage forms

Mashhour Ghanem 1 and Saleh Abu-Lafi 2 * ABSTRACT ARTICLE INFO

Chapter-4 EXPERIMENTAL WORK BY RP-HPLC

Research Article. Figure 1. Chemical structure of doxofylline. Indonesian J. Pharm. Vol. 24 No. 1 : ISSN-p :

RESEARCH ARTICLE ANALYTICAL METHOD DEVELOPMENT OF TOLPERISONE HYDROCHLORIDE IN TABLET DOSAGE FORM BY UV VISIBLE SPECTROPHOTOMETRY.

RP-HPLC method for simultaneous estimation of amoxicillin and carbocisteine in dosage forms

International Journal of PharmTech Research CODEN (USA): IJPRIF, ISSN: , ISSN(Online): Vol.9, No.7, pp , 2016

ISSN: ; CODEN ECJHAO E-Journal of Chemistry , 9(1), 35-42

Department of Pharmaceutical Chemistry, Poona College of Pharmacy, Bharati Vidyapeeth University, Erandwane, Pune , India

Available Online through

AND VALIDATION FOR SIMULTENEOUS ESTIMATION OF AMBROXOL HYDROCHLORIDE AND DOXOFYLLINE IN PHARMACEUTICAL DOSAGES FORMS AND BULK DRUGS BY RP-HPLC METHOD

Pelagia Research Library

Development and Validation of UV Spectrophotometric Estimation of Diclofenac Sodium Bulk and Tablet Dosage form using Area under Curve Method

Simultaneous estimation and validation of bromhexine and cephalexin in bulk and pharmaceutical dosage form by RP-HPLC method

Simultaneous HPLC Determination of Methocarbamol, Paracetamol and Diclofenac Sodium

Development and Validation of Sensitive RP-HPLC Method for the Estimation of Glibenclamide in Pure and Tablet Dosage Forms

Radhakrishnan K. et al. / International Journal of Pharmacy & Therapeutics, 3(1), 2012, e- ISSN Print ISSN

B. Anupama et al. IRJP 2 (1)

Sumathi Gracy et al. Int. Res. J. Pharm. 2014, 5 (4) INTERNATIONAL RESEARCH JOURNAL OF PHARMACY

Development and validation of stability indicating reverse phase high performance liquid chromatography method for Timolol Maleate

KEYWORDS: Acetaminophen, Doxylamine succinate, Dextromethorphan hydrobromide.

Ketorolac tromethamine (KT)[1] is

Development and Validation of Stability Indicating Assay Method of Etodolac by using UV-Visible Spectrophotometer

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

Simultaneous estimation of amitryptyline and chlordiazepoxide by RP-HPLC method

International Journal of Research and Reviews in Pharmacy and Applied science.

Saudi Journal of Medical and Pharmaceutical Sciences

Development and validation of septrophotometricmethods for the estimation of rasagiline in tablet doage form

HPLC Method Development and Validation for the estimation of Esomeprazole in Bulk and Pharmaceutical Dosage Form

International Journal of Pharma and Bio Sciences

DEVELOPMENT AND VALIDATION OF A HPLC METHOD FOR IN-VIVO STUDY OF DICLOFENAC POTASSIUM

Transcription:

Research Article ISSN: 0974-6943 M.V.Kumudhavalli et al. / Journal of Pharmacy Research 2014,8(11), Available online through http://jprsolutions.info Reverse Phase High Performance Liquid Chromatography method for determination of Lercanidipine hydrochloride in bulk and tablet dosage form M.V. Kumudhavalli*,Venkatesh. P, B. Jaykar, Palanisamy. P Department of Pharmaceutical Anaylsis, Vinayaka Mission s College of Pharmacy, Vinayaka Missions University, Yercaud Main Road, Kondappanickenpatty, Salem, Tamil Nadu, India Received on:17-09-2014; Revised on: 09-10-2014; Accepted on:21-11-2014 ABSTRACT A simple, sensitive and rapid reverse phase performance liquid chromatography (RP-HPLC) method was development for the determination of Lercanidipine hydrochloride. The HPLC analysis was performed on the Phenomenex Luna C 18 (250 mm 4.60 mm), 5µm particle size in isocratic mode, at 25 0 C temperature using a mobile phase consisting of methanol: water (95:5 v/v), at a flow rate of. The detection was carried out at 237 nm. The average retention time for LCD was found to be 5.38 min. Linearity was observed in the concentration range 4-28 µg/ml (r 2 = 0.998).The method has been successively applied for the determination of LCD in tablets. There was no interference from the excipients commonly present in tablets. The drug content was found to be 99.51 %. Accuracy of the method was checked by recovery experiments at three different levels 80 %, 100 % and 120 %. The mean percentage recovery was found to be within the limits of acceptance criteria with average recovery in the range 99.07 100.12%. The % R.S.D. below 2.0 proved accuracy of proposed method. The results did not show any statistical difference between operators and they suggesting the methods developed was rugged. System suitability tests are an integral part of chromatographic methods. To ascertain its effectiveness, system suitability tests were carried out on freshly prepared stock solution. The method used for the above developed method is precise, accurate, simple and easy for routine analysis. KEYWORDS:Lercanidipine hydrochloride, Linearity and RP-HPLC INTRODUCTION HPLC is a type of liquid chromatography that employs a liquid mobile phase and a very finely divided stationary phase. The technique of high performance liquid chromatography is so called because of its improved performance when compared to column chromatography. Advances in column technology, high-pressure pumping system and sensitive detectors have transformed liquid column chromatography into high speed, efficient, accurate and highly resolved method of separation 1-2. Lercanidipine hydrochloride, a dihydropyridine calcium channel blocker used in the treatment of hypertension. Lercanidipine hydrochloride is available in the tablet dosage form. In literature, very few methods are reported for determination of lercanidipine hydrochloride in pharmaceutical formulations. Therefore, it was thought *Corresponding author. R.Margret Chandira, M. Pharmacy.,Ph.D., Department of Pharmaceutics, Vinayaka Mission s College of Pharmacy, Yercaud Main Road, Kondappanaickanpatty (Post), Salem (D.T),India meaningful. To develop simple, rapid, specific and sensitive RP-HPLC method for the determination of Lercanidipine hydrochloride in tablet dosage form for a routine analysis. To validate the method according to ICH guidelines. MATERILA AND METHODS: Experimental Work Chemicals Lercanidipine hydrochloride 3-5 was gifted by Central Drug Research Institute, (Lucknow). Acetonitrile, triethylamine, methanol, ortho-phosphoric acid, potassium dihydrogen phosphate, ammonium acetate, and tripple distil water were procured from Merck Laboratories. selection of wavelength: Appropriate volume 1.0 ml of standard stock LCD was transferred to 10 ml amber glass volumetric flask and the volume was adjusted to the mark with same solvent i.e 10 µg/ml. The solution was scanned in the UV range 200-400 nm. The spectrum of LCD was recorded.

M.V.Kumudhavalli et al. / Journal of Pharmacy Research 2014,8(11), instrument and washed with Double Distilled water for. Then run the mobile phase for for column saturation. Trial- 1 Table. No :1 Chromatographic conditions for trial-1 Mobile Phase Methanol (100%) 1.0ml/min Temperature Ambient Fig. No. 1 : U.V Spectra of LCD Observation : The drug was shown? max at 237 nm Conclusion : Hence this wavelength was selected for RP-HPLC method analysis. Method Development for the Assay of Lercanidipine Hcl by Reverse Phase HPLC Preparation of solutions Preparation of Mobile Phase: Mobile phases such as methanol, water and varying proportions of methanol: water were tried to achieve separation of LCD. A mobile phase consist of methanol: water in (100%, 80:20, 90:10, 95:5 v/v respectively) was selected to achieve symmetrical peak and sensitivity. The effects of flow rates in the range 0.9-1.1 ml/min were examined. Preparation of standard solution: Standard stock solution was prepared by dissolving 10 mg of LCD in 100 ml methanol that gives concentration 100µg/ml. Fig. No. 1: Chromatogram for Chromatographic condition 1 Observation : No Peak was observed. Trial- 2 Table. No :2 Chromatographic conditions for trial-2 Mobile Phase Methanol: Water(80:20) 1.0ml/min Temperature Ambient Preparation of sample solution: Accurately weighed quantity 10 mg of LCD was transferred to 100 ml calibrated volumetric flask, dissolved in methanol and the volume was adjusted to the mark. The solution was further diluted to get concentration of 10 µg/ml, subjected to analyses and amount of LCD was determined. Initialization of the Instrument First, the column was placed on the instrument and switch on the Fig. No. 2 : Chromatogram for Chromatographic condition

Observation : No peak was observed. Trial- 3 M.V.Kumudhavalli et al. / Journal of Pharmacy Research 2014,8(11), Table. No : 3 Chromatographic conditions for trial-3 Mobile Phase Methanol: Water(90:10) 1.5ml/min Temperature Ambient Observation : The retention time of Lercanidipine was 5.38 min Conclusion : Theoretical plate value was observed as 4526. A single peak was eluted, and the peak symmetry was good. Hence this condition was selected for validation process. Validation of Developed Method The developed method was validated according to ICH guidelines. The mobile phase was prepared and arranged all parameter as per the above optimized method. Validation 6-9 1. System suitability 2. Precision 3. Accuracy (recovery) 4. Linearity of test method 5. Robustness of test method RESULTS AND DISCUSSION Validation data 1. System suitability: Table. No: 5 Result of system suitability parameters for Lercanidipine Fig. No. 3 :Chromatogram for Chromatographic condition 3 Observation : Broad peak was observed. Optimized Method Table. No :4 Chromatographic conditions for the optimized method. System RT AUC No. of Tailing suitability theoretical factor Parameter plates Rep-1 5.40 508506 4535 1.2 Rep-2 5.36 513795 4515 1.5 Rep-3 5.37 510910 4516 1.4 Mean 5.38 511070.33 4522 1.3666 S.D. 0.020 2648.14 11.26 0.1527 % R.S.D. 0.5181 Chromatogram of System Suitability Mobile Phase Methanol: Water(95:5) Temperature Ambient Fig. No. 5 Chromatogram of System Suitability of Lercanidipine HCL Observation : Retention time was observed at 5.37 Result : Standard solution Lercanidipine HCL was determined under proposed condition chromatogram indicating satisfactory retention time and area. Fig. No. 4 : Chromatogram for optimized Chromatographic condition 4

2. Precision M.V.Kumudhavalli et al. / Journal of Pharmacy Research 2014,8(11), Observation: Retention time was observed at 5.41 Table. No: 6 Data for intra-day Conc. AUC MEAN S.D %RSD (µg/ml) REP-1 REP-2 REP-3 8 508495 508525 508546 508522 25.63 0.0050 12 513770 513798 513816 513794 23.18 0.00451 16 511090 511105 511130 511108 20.20 0.00395 Table. No: 7 Data for inter-day Conc. AUC MEAN S.D %RSD (µg/ml) REP-1 REP-2 REP-3 8 509131 509167 509201 509166 35.004 0.0068 12 514801 514868 514890 514853 46.36 0.009 16 511210 511288 511321 511273 57 0.011 Chromatograms of Precision Fig. No. 8 Chromatogram of Lercanidipine HCL at 12 µg/ml concentration: Observation : Retention time was observed at 5.33 Fig. No. 6 Chromatogram of Repeatability of Lercanidipine HCL Observation :Precision %RSD was found to be 1.3%, 0.8% and 0.1 for Repeatability, Analyst 1 and Analyst 2 respectively. This indicates that the method is precise. Intra Day Precision Fig. No. 9 Chromatogram of Lercanidipine HCL at 16 µg/ml concentration Observation: Retention time was observed at 5.375 Intra Day Precision Fig. No. 10 Chromatogram of Lercanidipine HCL at 8 µg/ml concentration Fig. No. 7 Chromatogram of Lercanidipine HCL at 8µg/ml concentration

M.V.Kumudhavalli et al. / Journal of Pharmacy Research 2014,8(11), Observation : Retention time was observed at 5.376 Chromatograms of Accuracy Fig. No. 11 Chromatogram of Lercanidipine HCL at 12 µg/ml concentration Observation: Retention time was observed at 5.307 Fig. No. 13 Chromatogram of Accuracy 80 % Lercanidipine HCL Sample Observation: Retention time was observed at 5.300 Fig. No. 12 Chromatogram of Lercanidipine HCL at 16 µg/ml concentration Observation: Retention time was observed at 5.453 Fig. No. 14 Chromatogram of Accuracy 100% Lercanidipine HCL Sample Observation: Retention time was observed at 5.365 Result:The R. S. D of Lercanidipine HCL was found to be presence with in the limits (<2%). 3. Accuracy Table. No: 8 Accuracy of proposed HPLC method %Concentration % Recovery Lercanidipine 80 99.07 100 99.36 120 100.12 MEAN 99.51 S.D. 0.5 % R.S.D. 0.502 Fig. No. 15 Chromatogram of Accuracy 120% Lercanidipine HCL Sample

M.V.Kumudhavalli et al. / Journal of Pharmacy Research 2014,8(11), Observation: Retention time was observed at 5.390 Result:The S. D and R. S. D of Lercanidipine HCL were found to be 0.5 and 0.502. 4. Linearity Table. No: 9 Linearity and calibration data of Lercanidipine Conc.(µg/ml) Area under curve(auc) replicates Mean Rep-I Rep-II Rep-III 4 224796 224840 224819 224818 8 421796 421859 421920 421858 12 601416 601536 601475 601476 16 809718 809803 809886 809802 20 969470 969449 969426 969448 24 1190171 1190214 1190130 1190171 28 1385144 1385096 1385920 1385141 r2 0.998 Slop 48085 Intercept 31022 Table. No: 12 Chromatogram of Lercanidipine HCL at flow rate at 0.9 ml/min: Mobile Phase Methanol: Water(95:5) Temperature Ambient Fig. No. 17 Chromatogram of Lercanidipine HCL e at flow rate at 0.9 ml/min Observation: Retention time was observed at 5.99 Table. No: 13 Chromatogram of Lercanidipine HCL at flow rate at 1.1 ml/min: Fig. No. 16 Linearity Graph of Lercanidipine Hcl 5. Robustness Data variability: Table. No: 10 Effect of variation in the flow rate of (0.9 ml/min) for Lercanidipine Mobile Phase Methanol: Water(95:5) Temperature Ambient Area Retention time Rep-1 514860 5.99 Rep-2 515112 6.08 Lercanidipine Rep-3 515096 6.02 Mean 515023 6.03 S.D. 115.10 0.037 % RSD 0.0223 0.61 Table. No: 11 Effect of variation in the flow rate of (1.1 ml/min) for Lercanidipine Area Retention time Rep-1 514994 4.62 Rep-2 515164 4.78 Lercanidipine Rep-3 515210 5.10 Mean 515123 4.83 S.D. 92.89 0.024 % RSD 0.01803 0.496 Fig. No. 18 Chromatogram of Lercanidipine HCL at flow rate at 1.1 ml/min

M.V.Kumudhavalli et al. / Journal of Pharmacy Research 2014,8(11), Observation : Retention time was observed at 5.10 Mobile phase variability: Table. No: 14 Data for mobile phase Methanol: water (94:06): Area Retention time Rep-1 515209 6.05 Lercanidipine Rep-2 515303 6.25 Rep-3 515292 5.74 Mean 515268 6.01 S.D. 41.06 0.0209 % RSD 0.0079 0.3477 Table. No: 15 Data for mobile phase Methanol: water (96:04): Lercanidipine Area Retention time Rep-1 516094 5.21 Rep-2 516136 5.12 Rep-3 516208 5.03 Mean 516146 5.12 S.D. 47.07 0.03 % RSD 0.0091 0.59 Table. No: 16 Chromatogram of Lercanidipine HCL in Methanol: Water (94:06) mobile phase Mobile Phase Methanol: Water(94:06) Temperature Ambient Fig. No. 20 Chromatogram of LercanidipineHCL in Methanol: Water (96:04) mobile phase Observation: Retention time was observed at 5.12 Observation: The % RSD was found within the limits. The all-individual assays of tablets should be within 98% to 102%. Result: Comparison of the results obtained on two different systems and s, showed that the assay test method were rugged for system-to-system variability, mobile phase and flow rate variability s. Table. No: 18 Validation Protocol Summary S.N Validation parameters Lercanidipine Fig. No. 19 Chromatogram of Lercanidipine HCL in Methanol: Water (94:06) mobile phase Observation: Retention time was observed at 6.05 Table. No: 17 Chromatogram of Lercanidipine HCL in Methanol: Water (96:04) mobile phase: Mobile Phase Methanol: Water(96:04) Temperature Ambient 1 Linearity (r 2 ) 0.998 2 Precision (%RSD) Intra- Day 8ppm 0.0050 12ppm 0.00451 16ppm 0.0039 Inter-Day 8ppm 0.00687 12ppm 0.009 16ppm 0.0111 3 Accuracy by recovery study (% RSD found) 0.502 4 Robustness(%RSD) a) of (0.9 ml/min) 0.0223 b) of (1.1 ml/min) 0.01803 c) Mobile phase Methanol: water (94:06) 0.0079 d) Mobile phase Methanol: water (94:06) 0.0091 SUMMARY AND CONCLUSION Lercanidipine hydrochloride (LCD), is dihydropyridine calcium and act a channel blocker which is used in the treatment of hypertension. The UV Spectra of LCD show maximum absorbance at 237nm in methanol. Hence the max was selected for further RPHPCL method development. RP-HPLC method has been developed for estimation of LCD in bulk and tablet formulation. The HPLC analysis was performed on the Phenomenex Luna C 18 (250 mm 4.60 mm), 5µm particle size in isocratic mode, at 25 0 C temperature using a mobile phase consisting of methanol: water (95:5 v/v), at a flow rate of. The detection was carried out at 237 nm. The average retention time for LCD was found to be 5.38 min.

M.V.Kumudhavalli et al. / Journal of Pharmacy Research 2014,8(11), Linearity was observed in the concentration range 4-28 µg/ml (r 2 = 0.998).The method has been successively applied for the determination of LCD in tablets. There was no interference from the excipients commonly present in tablets. The drug content was found to be 99.51 %. Accuracy of the method was checked by recovery experiments at three different levels 80 %, 100 % and 120 %. The mean percentage recovery was found to be within the limits of acceptance criteria with average recovery in the range 99.07 100.12%. The % R.S.D. below 2.0 proved accuracy of proposed method. The results did not show any statistical difference between operators and they suggesting the methods developed was rugged. System suitability tests are an integral part of chromatographic methods. They are used to verify the reproducibility of the chromatographic system. To ascertain its effectiveness, system suitability tests were carried out on freshly prepared stock solution. From this present study it is clear that the above developed method is precise, accurate, simple and easy for routine analysis. ACKNOWLEDGEMENTS Authors are thankful to Prof (Dr.).B.Jaykar, Principal Vinayaka Mission s College of Pharmacy, Salem, Tamil nadu and providing all the facilities for this research project. REFERENCES 1. Snyder LR, Kirkland JJ and Glajch LJ (1997) Practical HPLC Method Development, 2 nd edn, John Wiley and Sons, INC, pp- 12. 2. Sethi PD (1996) HPTLC: Quantitative Analysis of Pharmaceutical Formulation, CBS Publications, New Delhi, pp- 162-165. 3. Maryadele JO Neil (2006) The Merck Index, Eds. In, 14th edn, Published by Merck and Co, White House Station, NJ, USA, pp.942. 4. Sweetman SC, Martindale (2007) The Extra Pharmacopoeia, The complete Drug Reference, 35 th edn,pharmaceutical Press, London, 2007, pp-1189 5. British Pharmacopoeia, Vol. I, HMSO, Cambridge, International edn, 2005, pp.179 6. Reviewer Guidance, Validation of Chromatographic Methods (CDER), Nov.1994. 7. ICH Guidelines Q2A, Validation of Analytical Procedures: Definition and terminology (CPMP III/5626/94) March (1995) Geneva, Switzerland. 8. ICH Guidelines Q2B, Validation of Analytical Procedures: Methodology (CPMP/ICH/281/95) November (1996) Geneva, Switzerland. 9. Indian Pharmacopoeia, Vol-I, Govt. of India, The Controller of Publication, New Delhi, 1996, pp-72. Source of support: Nil, Conflict of interest: None Declared